Astellas Pharma - Evolving practice in advanced gastric cancer: Biomarker-guided therapy and emerging perspectives in HER2 negative disease

Name: Astellas Pharma - Evolving practice in advanced gastric cancer: Biomarker-guided therapy and emerging perspectives in HER2 negative disease
Start: 2026-12-04T12:30
End: 2026-12-04T14:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 4 December 2026 · 12:30–14:00 · Hall 407

Astellas Pharma - Evolving practice in advanced gastric cancer: Biomarker-guided therapy and emerging perspectives in HER2 negative disease was a session at ESMO Asia 2026 on 4 December 2026 in Singapore, with 4 speakers on record.

Speakers

Matthew Chau Hsien Ng — Chair NCCS - National Cancer Centre Singapore
Ming-Huang Chen — Panelist Taipei Veterans General Hospital
Kohei Shitara — Panelist National Cancer Center Hospital East
Sun Young Rha — Panelist Severance Hospital - Yonsei University College of Medicine